News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Respirics, Inc. Announces Intention to Divest MD Turbo(TM) Assets


6/13/2007 1:33:47 PM

RALEIGH, N.C.--(BUSINESS WIRE)--Respirics Inc. announced today that it has decided to divest its assets relating to MD Turbo®. MD Turbo was cleared by the FDA for marketing in 2005 and was launched in the U.S. last year. MD Turbo, the company’s first commercial device, is a companion product designed to assist patients who use pressurized metered dose inhalers (pMDI) for asthma and COPD; the incidence of these diseases in the US alone is over 40 million. MD Turbo solves two major challenges patients have with proper pMDI use: coordination of inhaler actuation with patient inhalation and accounting for how much medication is in an inhaler at any given time.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES